Literature DB >> 19335689

Toxic epidermal necrolysis successfully treated with etanercept.

Emanuela Gubinelli1, Flora Canzona, Tiziano Tonanzi, Desanka Raskovic, Biagio Didona.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare and acute severe adverse reaction to drugs, characterised by massive apoptosis and widespread epidermal and mucosal detachment. Although no gold standard therapy exists, human i.v. immunoglobulins have recently been described as an effective treatment for this disease. We report a case of phenobarbital-induced TEN in a 59-year-old white woman where the epidermal detachment stopped 48 h after beginning the etanercept treatment with complete healing after 20 days. To the best of our knowledge, this is only the second reported case of TEN successfully treated with etanercept.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19335689     DOI: 10.1111/j.1346-8138.2009.00616.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  21 in total

1.  Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Authors:  Chuang-Wei Wang; Lan-Yan Yang; Chun-Bing Chen; Hsin-Chun Ho; Shuen-Iu Hung; Chih-Hsun Yang; Chee-Jen Chang; Shih-Chi Su; Rosaline Chung-Yee Hui; See-Wen Chin; Li-Fang Huang; Yang Yu-Wei Lin; Wei-Yang Chang; Wen-Lang Fan; Chin-Yi Yang; Ji-Chen Ho; Ya-Ching Chang; Chun-Wei Lu; Wen-Hung Chung
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

Review 2.  Skin manifestations of drug allergy.

Authors:  Michael R Ardern-Jones; Peter S Friedmann
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

3.  Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Treatment With a Biologic: A Case Report.

Authors:  Ian Chong; Alice Chao
Journal:  Perm J       Date:  2017

Review 4.  Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.

Authors:  Stefanie Zimmermann; Peggy Sekula; Moritz Venhoff; Edith Motschall; Jochen Knaus; Martin Schumacher; Maja Mockenhaupt
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

5.  Stevens-Johnson syndrome in a patient with rheumatoid arthritis during long-term etanercept therapy.

Authors:  Agnieszka Owczarczyk-Saczonek; Natalia Zdanowska; Aleksandra Znajewska-Pander; Waldemar Placek
Journal:  J Dermatol Case Rep       Date:  2016-03-31

Review 6.  SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.

Authors:  Katie D White; Riichiro Abe; Michael Ardern-Jones; Thomas Beachkofsky; Charles Bouchard; Bruce Carleton; James Chodosh; Ricardo Cibotti; Robert Davis; Joshua C Denny; Roni P Dodiuk-Gad; Elizabeth N Ergen; Jennifer L Goldman; James H Holmes; Shuen-Iu Hung; Mario E Lacouture; Rannakoe J Lehloenya; Simon Mallal; Teri A Manolio; Robert G Micheletti; Caroline M Mitchell; Maja Mockenhaupt; David A Ostrov; Rebecca Pavlos; Munir Pirmohamed; Elena Pope; Alec Redwood; Misha Rosenbach; Michael D Rosenblum; Jean-Claude Roujeau; Arturo P Saavedra; Hajirah N Saeed; Jeffery P Struewing; Hirohiko Sueki; Chonlaphat Sukasem; Cynthia Sung; Jason A Trubiano; Jessica Weintraub; Lisa M Wheatley; Kristina B Williams; Brandon Worley; Wen-Hung Chung; Neil H Shear; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jan - Feb

Review 7.  Cutaneous Drug Reactions in the Elderly.

Authors:  James W S Young; Neil H Shear
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 4.271

Review 8.  Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

Authors:  Audrey Jacobsen; Bayanne Olabi; Annie Langley; Jennifer Beecker; Eric Mutter; Amanda Shelley; Brandon Worley; Timothy Ramsay; Arturo Saavedra; Roses Parker; Fiona Stewart; Jordi Pardo Pardo
Journal:  Cochrane Database Syst Rev       Date:  2022-03-11

9.  Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial.

Authors:  Reason Wilken; Chin Shang Li; Victoria R Sharon; Kyoungmi Kim; Falin B Patel; Forum Patel; Emanual Maverakis
Journal:  Trials       Date:  2015-08-22       Impact factor: 2.279

Review 10.  Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective.

Authors:  Bernard Yu-Hor Thong
Journal:  Asia Pac Allergy       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.